Advanced Prostate – Call For Grant (3) – Quality of life and patient‑centered care in advanced prostate cancer
Bayer funds educational initiatives to enhance quality of life and patient-centered care in advanced prostate cancer, focusing on evidence-based approaches, cognitive outcomes, and survivorship.
Funder: Bayer
Due Dates: Rolling (Monthly review; allow 45 days for response)
Funding Amounts: Not specified; budget required in proposal; awards typically support educational initiatives.
Summary: Supports educational projects to improve quality of life and patient-centered care in advanced prostate cancer.
Description
This Bayer grant supports educational initiatives focused on improving the quality of life, cognitive function, and patient-centered care for individuals with advanced prostate cancer. Targeted disease states include non-metastatic castrate resistant (nmCRPC), metastatic castrate resistant (mCRPC), and metastatic hormone-sensitive prostate cancer (mHSPC). The grant emphasizes evidence-based approaches, particularly those addressing the impact of androgen receptor pathway inhibitors, neurocognitive and functional outcomes, and pragmatic evaluation of patient-reported outcomes within survivorship care. Projects should aim to inform treatment selection, counseling, and shared decision-making, while addressing evidence gaps and practical challenges in the field.
